Evaluation of syncope in patients referred to afshar heart clinic, yazd, iran from september 2016 to march 2017

Document Type : original articles

Authors

1 Shiraz University of Medical Sciences, Dermatology Department of Shahid Faghihi Hospital, Shiraz, Iran

2 Yazd Cardiovascular Research Center, Non- communicable Diseases Research Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

Abstract

Objectives: Syncope is defined as a sudden and transient loss of consciousness followed by complete spontaneous recovery. This study describes the syncope evaluation in patients referred to the Heart Clinic.
Methods: This descriptive cross-sectional study was conducted on 60 syncope patients referred to Afshar Heart Clinic of Yazd, Iran, from September 2016 to March 2017. After performing clinical workups, the etiology of syncope was diagnosed in each patient. Electrocardiography and blood pressure measurements were done for all patients. Additional clinical tests, including echocardiography, Holter Monitoring, Head-Up tilt table test (HUTT), electroencephalography, and Magnetic Resonance Imaging, were performed for some patients based on the cardiologist's opinion. The distribution of patient's clinical records, such as age, sex, diabetes, hypertension, history of ischemic heart disease (IHD), duration of syncope, postdrome, prodromal symptoms, and clinical test results according to causes of syncope in patients, were reported.
Results: Sixty patients with a mean age of 50.7 ± 20.4 years were evaluated (55% male). Thirty-five patients (58.3%) had Neurally Mediated Syncope, 18 patients (30%) had arterioventricular (AV) Block induced syncope, and 7 (11.7%) patients had Sick Sinus Syndrome (SSS) induced syncope. Age, hypertension, prodromal symptoms, history of IHD, ECG, Holter monitoring, and HUTT results were associated with the cause of the syncope.
Conclusions: Cardiac syncopes (AV-Block induced and SSS induced) were related to older age, hypertension, abnormal electrocardiogram, and abnormal Holter monitoring results. Neurally mediatedsyncope was associated with younger age, prodromal symptoms, and abnormal HUTT results.

Keywords


References
1.Brignole M, Moya A, de Lange FJ, et al. 2018 ESC Guidelines for the diagnosis and management of syncope. Eur Heart J. 2018;39(21):1883-1948.
2.Savage DD, Corwin L, McGee DL, et al. Epidemiologic features of isolated syncope: the Framingham Study. Stroke. 1985;16(4):626-9.
3.Sandhu RK, Sheldon RS. Syncope in the Emergency Department. Front Cardiovasc Med. 2019;6:180.
4.Alshekhlee A, Shen WK, Mackall J, et al. Incidence and mortality rates of syncope in the United States. Am J Med. 2009;122(2):181-8.
5.Joy PS, Kumar G, Olshansky B. Syncope: Outcomes and Conditions Associated with Hospitalization. Am J Med. 2017;130(6):699-706 e6.
6.Sun BC, Emond JA, Camargo CA Jr. Direct medical costs of syncope-related hospitalizations in the United States. Am J Cardiol. 2005;95(5):668-71.
7.Soteriades ES, Evans JC, Larson MG, et al. Incidence and prognosis of syncope. N Engl J Med. 2002;347(12):878-85.
8.Adler A, Rosso R, Chorin E, et al. Risk stratification in Brugada syndrome: Clinical characteristics, electrocardiographic parameters, and auxiliary testing. Heart Rhythm. 2016;13(1):299-310.
9.Spirito P, Autore C, Rapezzi C, et al. Syncope and risk of sudden death in hypertrophic cardiomyopathy. Circulation. 2009;119(13):1703-10.
10.Aro AL, Rusinaru C, Uy-Evanado A, et al. Syncope and risk of sudden cardiac arrest in coronary artery disease. Int J Cardiol. 2017;231:26-30.
11.Wehrens XH, Vos MA, Doevendans PA, et al. Novel insights in the congenital long QT syndrome. Ann Intern Med. 2002;137(12):981-92.
12.Manolis AS, Linzer M, Salem D, et al. Syncope: current diagnostic evaluation and management. Ann Intern Med. 1990;112(11):850-63.
13.Sun BC. Quality-of-life, health service use, and costs associated with syncope. Prog Cardiovasc Dis. 2013;55(4):370-5.
14.Kachalia A, Berg A, Fagerlin A, et al. Overuse of testing in preoperative evaluation and syncope: a survey of hospitalists. Ann Intern Med. 2015;162(2):100-8.
15.Jorge JG, Raj SR, Teixeira PS, et al. Likelihood of injury due to vasovagal syncope: a systematic review and meta-analysis. Europace. 2021;23(7):1092-1099.
16.Kapoor WN, Fortunato M, Hanusa BH, et al. Psychiatric illnesses in patients with syncope. Am J Med. 1995;99(5):505-12.
17.Krol RB, Morady F, Flaker GC, et al. Electrophysiologic testing in patients with unexplained syncope: clinical and noninvasive predictors of outcome. J Am Coll Cardiol. 1987;10(2):358-63.
18.Hurst D, Hirsh DA, Oster ME, et al. Syncope in the pediatric emergency department–can we predict cardiac disease based on history alone? J Emerg Med. 2015;49(1):1-7.
19.Del Rosso A, Ungar A, Maggi R, et al. Clinical predictors of cardiac syncope at initial evaluation in patients referred urgently to a general hospital: the EGSYS score. Heart. 2008;94(12):1620-6.
20.Shen WK, Sheldon RS, Benditt DG, et al. 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2017;70(5):620-663.
21.Georgeson S, Linzer M, Griffith JL, et al. Acute cardiac ischemia in patients with syncope: importance of the initial electrocardiogram. J Gen Intern Med. 1992;7(4):379-86.
22.Runser LA, Gauer RL, Houser A. Syncope: Evaluation and Differential Diagnosis. Am Fam Physician. 2017;95(5):303-312.
23.Zhang Q, Zhu L, Wang C, et al. Value of history taking in children and adolescents with cardiac syncope. Cardiol Young. 2013;23(1):54-60.
24.Ghani AR, Ullah W, Abdullah HMA, et al. The role of echocardiography in diagnostic evaluation of patients with syncope-a retrospective analysis. Am J Cardiovasc Dis. 2019;9(5):78-83.
25.Madeira CL, Craig MJ, Donohoe A, et al. Things We Do For No Reason: Echocardiogram in Unselected Patients with Syncope. J Hosp Med. 2017;12(12):984-988.
26.Satish M, Walters RW, Alla VM. Trends in use of echocardiography in hospitalized patients with syncope. Echocardiography. 2019;36(1):7-14.
27.Giada F, Bartoletti A. Value of ambulatory electrocardiographic monitoring in syncope. Cardiol Clin. 2015;33(3):361- 6.
28.Hadjikoutis S, O'Callaghan P, Smith PE. The investigation of syncope. Seizure. 2004;13(8):537-48.
29.Sarasin FP, Carballo D, Slama S, et al. Usefulness of 24-h Holter monitoring in patients with unexplained syncope and a high likelihood of arrhythmias. Int J Cardiol. 2005;101(2):203-7.
30.Krahn AD, Klein GJ, Yee R, et al. Cost implications of testing strategy in patients with syncope: randomized assessment of syncope trial. J Am Coll Cardiol. 2003;42(3):495-501.
31.Benditt DG, Ferguson DW, Grubb BP, et al. Tilt table testing for assessing syncope. American College of Cardiology. J Am Coll Cardiol. 1996;28(1):263-75.
32.Kohno R, Adkisson WO, Benditt DG. Tilt table testing for syncope and collapse. Herzschrittmacherther Elektrophysiol. 2018;29(2):187-192.
33.Barón-Esquivias G, Martín AJD, Del Castillo ÁM, et al. Head-up tilt test diagnostic yield in syncope diagnosis. J Electrocardiol. 2020;63:46-50.
34.Day SC, Cook EF, Funkenstein H, et al. Evaluation and outcome of emergency room patients with transient loss of consciousness. Am J Med. 1982;73(1):15-23.
35.Davis TL, Freemon FR. Electroencephalography should not be routine in the evaluation of syncope in adults. Arch Intern Med. 1990;150(10):2027-9.
36.İdil H, Kılıc TY. Diagnostic yield of neuroimaging in syncope patients without high-risk symptoms indicating neurological syncope. Am J Emerg Med. 2019;37(2):228-230.
37.Dantas FG, Cavalcanti AP, Rodrigues Maciel BD, et al. The role of EEG in patients with syncope. J Clin Neurophysiol. 2012;29(1):55-7.